You are here

  • Home
  • Archive
  • Volume 42, Issue 4
  • Commentary on ‘Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK’

Article metrics

Article menu

Download PDFPDF

Research
Commentary
Commentary on ‘Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK’
Free

 

Online download statistics by month:

Online download statistics by month: September 2016 to March 2024

AbstractFullPdf
Sep 201665814
Oct 2016841010
Nov 20164950
Dec 20165022
Jan 20172211
Feb 20171931
Mar 20173320
Apr 20172500
May 20174731
Jun 20173232
Jul 20172800
Aug 20175100
Sep 20175300
Oct 201710211
Nov 201719647
Dec 20173623
Jan 20183401
Feb 20183913
Mar 20183610
Apr 20182200
May 20182500
Jun 20182000
Jul 20183500
Aug 20182900
Sep 20184531
Oct 2018662
Nov 2018880
Dec 201823231
Jan 201914130
Feb 201916142
Mar 201917164
Apr 2019665
May 2019661
Jun 201910101
Jul 201912123
Aug 201912123
Sep 201914132
Oct 2019555
Nov 201910108
Dec 2019997
Jan 2020773
Feb 2020995
Mar 2020666
Apr 2020441
May 2020993
Jun 2020640
Jul 202010103
Aug 2020114
Sep 202012111
Oct 202011107
Nov 202012126
Dec 202013132
Jan 2021882
Feb 2021117
Mar 2021333
Apr 2021874
May 2021553
Jun 202121213
Jul 2021337
Aug 2021336
Sep 202120169
Oct 20218719
Nov 20217615
Dec 2021771
Jan 202210101
Feb 2022561
Mar 202219194
Apr 2022982
May 2022232211
Jun 202221204
Jul 202213112
Aug 202222202
Sep 202222225
Oct 2022222112
Nov 2022982
Dec 2022330
Jan 2023114
Feb 202329282
Mar 2023550
Apr 2023111
May 202310911
Jun 2023444
Jul 2023226
Aug 2023332
Sep 2023874
Oct 2023330
Nov 202315111
Dec 202324214
Jan 2024223
Feb 2024559
Mar 2024161633
Total1845683341